Leucocyte and eosinophil counts predict progression-free survival in relapsed or refractory classical Hodgkin Lymphoma patients treated with PD1 inhibition.
Ida Hude DragičevićStephanie SassePaul J BröckelmannBastian von TresckowJesko MomotowAndreas EngertSven BorchmannPublished in: British journal of haematology (2017)